龙翔药业 (871082.OC)

+ 收藏

现金流量表(龙翔药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 83,750,420.93206,741,088.43125,091,771.49214,478,302.3793,545,088.09
 收到的税费返还(元) 1,388,156.415,181,176.123,668,942.588,389,742.651,859,266.66
 收到其他与经营活动有关的现金(元) 821,776.544,475,876.812,334,399.029,469,855.437,923,791.19
 经营活动现金流入小计(元) 85,960,353.88216,398,141.36131,095,113.09232,337,900.45103,328,145.94
 购买商品、接受劳务支付的现金(元) 65,202,209.85163,795,828.8390,135,152.28214,327,424.1778,352,061.02
 支付给职工以及为职工支付的现金(元) 12,771,355.7833,091,499.1417,527,234.5232,985,748.0816,921,645.87
 支付的各项税费(元) 3,693,731.352,365,500.791,356,298.631,748,132.26875,485.37
 支付其他与经营活动有关的现金(元) 10,253,852.136,831,279.733,060,628.179,963,943.173,748,886.65
 经营活动现金流出小计(元) 91,921,149.11206,084,108.49112,079,313.60259,025,247.6899,898,078.91
 经营活动产生的现金流量净额(元) -5,960,795.2310,314,032.8719,015,799.49-26,687,347.233,430,067.03
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) ---195,000.00-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---40,000.00-
 收到其他与投资活动有关的现金(元) 2,640.1221,094,324.96---
 投资活动现金流入小计(元) 2,640.1221,094,324.96-235,000.00-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 5,331,759.0010,556,862.965,446,653.7127,419,848.5317,881,435.99
 支付其他与投资活动有关的现金(元) 2,640.3421,094,764.98---
 投资活动现金流出小计(元) 5,334,399.3431,651,627.945,446,653.7127,419,848.5317,881,435.99
 投资活动产生的现金流量净额(元) -5,331,759.22-10,557,302.98-5,446,653.71-27,184,848.53-17,881,435.99
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 104,000,000.00113,000,000.00104,000,000.00177,500,000.0036,000,000.00
 收到其他与筹资活动有关的现金(元) 45,000,000.0063,000,254.9527,500,254.9582,622,017.9855,850,000.00
 筹资活动现金流入小计(元) 149,000,000.00176,000,254.95131,500,254.95260,122,017.9891,850,000.00
 偿还债务支付的现金(元) 109,998,500.00136,528,000.00120,014,000.00162,637,500.0058,850,000.00
 分配股利、利润或偿付利息支付的现金(元) 5,264,126.158,533,227.165,847,075.528,371,018.312,770,351.69
 支付其他与筹资活动有关的现金(元) 26,335,177.8333,861,302.0618,097,660.8863,048,369.4938,567,714.36
 筹资活动现金流出小计(元) 141,597,803.98178,922,529.22143,958,736.40234,056,887.80100,188,066.05
 筹资活动产生的现金流量净额(元) 7,402,196.02-2,922,274.27-12,458,481.4526,065,130.18-8,338,066.05
四、汇率变动对现金及现金等价物的影响(元) 266,326.6132,939.1326,833.0711,065.756,169.24
五、现金及现金等价物净增加额(元) -3,624,031.82-3,132,605.251,137,497.40-27,795,999.83-22,783,265.77
 加:期初现金及现金等价物余额(元) 6,990,670.1310,123,275.3810,123,275.3837,919,275.2137,919,275.21
 期末现金及现金等价物余额(元) 3,366,638.316,990,670.1311,260,772.7810,123,275.3815,136,009.44
补充资料:
 净利润(元) -13,237,947.18-4,330,407.441,159,096.22-16,880,029.131,220,514.40
 固定资产和投资性房地产折旧(元) 14,677,394.2529,360,349.5612,742,637.8613,368,203.162,553,283.52
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 14,677,394.2529,360,349.5612,742,637.8613,368,203.162,553,283.52
 无形资产摊销(元) 587,983.991,176,431.49588,447.511,190,534.02596,031.42
 处置固定资产、无形资产和其他长期资产的损失(元) ---734.28-
 公允价值变动损失(元) --1,300,000.00--720,000.00-
 财务费用(元) 5,931,498.9212,842,519.396,708,048.9213,001,751.005,641,103.22
 投资损失(元) ----195,000.00-195,000.00
 递延所得税(元) -2,824,622.58-2,097,992.02-732,530.35-4,735,283.97-124,454.18
  其中:递延所得税资产减少(元) -2,824,622.584,250,193.90-732,530.35-237,191.47-24,323,511.38
 递延所得税负债增加(元) --6,348,185.92--4,498,092.5024,199,057.20
 存货的减少(元) 23,959,211.875,591,350.67-12,523,123.07-15,990,566.586,209,490.22
 经营性应收项目的减少(元) -6,340,101.33-8,038,828.973,876,503.20-5,651,500.35-7,456,834.71
 经营性应付项目的增加(元) -23,776,099.38-24,122,704.255,571,922.14-16,426,482.73-6,387,002.63
 其他(元) -5,250,000.00----
 现金的期末余额(元) 3,366,638.316,990,670.1311,260,772.7810,123,275.3815,136,009.44
 减:现金的期初余额(元) 6,990,670.1310,123,275.3810,123,275.3837,919,275.2137,919,275.21
 现金及现金等价物的净增加额(元) -3,624,031.82-3,132,605.251,137,497.40-27,795,999.83-22,783,265.77
公告日期 2024-08-232024-03-292023-08-252023-03-312022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院